H. Kerkhofs

On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group.

Bob Löwenberg, R Zittoun, H. Kerkhofs et al. · Journal of Clinical Oncology · 1989 · 386 citations

Elderly Patients, Mixed-phenotype Acute Leukemia, Pharmacotherapy +16

Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases

H. Kerkhofs, J. Hermans, H. L. Haak et al. · British Journal of Haematology · 1987 · 193 citations

Prognostic Factors, Mixed-phenotype Acute Leukemia, Prognosis +16

The 5q‐ chromosome abnormality in haematological disorders:|a collaborative study of 34 cases from the Netheralands

H. Kerkhofs, A Hagemeijer, C. H. W. Leeksma et al. · British Journal of Haematology · 1982 · 82 citations

Genetics, Pathology, Haematological Disorders +16

A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia: A leukemia-lymphoma group trial of the EORTC

M. Hayat, U. Jehn, R. Willemze et al. · Cancer · 1986 · 45 citations

Longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia using archived blood smears

H van Kamp, C de Pijper, Matty Verlaan–de Vries et al. · Blood · 1992 · 40 citations · Full text